We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01281254
Recruitment Status : Terminated (Closure of long term follow up (LTFU) and study earlier than previously outlined in the protocol as no beneficial information gained from continuing LTFU.)
First Posted : January 21, 2011
Last Update Posted : December 2, 2017
Sponsor:
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : August 29, 2014
  Study Completion Date : April 19, 2017
  Certification or Request for Extension to Delay Results Submission: April 23, 2015